![Novartis _ Cardio Alex Exhibition 2Design & 3D Modelling: Hany Ibrahem | Booth design, Exhibition, Cardio Novartis _ Cardio Alex Exhibition 2Design & 3D Modelling: Hany Ibrahem | Booth design, Exhibition, Cardio](https://i.pinimg.com/originals/d9/5f/a8/d95fa8f6d6ce7a53733ca52baabaff87.jpg)
Novartis _ Cardio Alex Exhibition 2Design & 3D Modelling: Hany Ibrahem | Booth design, Exhibition, Cardio
![Cardio Metabolic Meeting - Cardiometabolic Novartis Transparent PNG - 3840x2715 - Free Download on NicePNG Cardio Metabolic Meeting - Cardiometabolic Novartis Transparent PNG - 3840x2715 - Free Download on NicePNG](https://www.nicepng.com/png/detail/274-2744217_cardio-metabolic-meeting-cardiometabolic-novartis.png)
Cardio Metabolic Meeting - Cardiometabolic Novartis Transparent PNG - 3840x2715 - Free Download on NicePNG
![Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease | Fierce Pharma Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1635941540/invisiblenation-globalhearthub.png?VersionId=V7NZJ1YVvFKkJ92w5Sh_W71qItGSco9n)
Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease | Fierce Pharma
![Cardiovascular Drugs Market to Exhibit a CAGR of 3.8% | Leading Players: Pfizer Inc, Bayer AG, AstraZeneca, Sanofi, Novartis AG, Merck & Co, Inc & more. | Medgadget Cardiovascular Drugs Market to Exhibit a CAGR of 3.8% | Leading Players: Pfizer Inc, Bayer AG, AstraZeneca, Sanofi, Novartis AG, Merck & Co, Inc & more. | Medgadget](https://www.medgadget.com/wp-content/uploads/2019/12/Cardiovascular-Drugs.png)
Cardiovascular Drugs Market to Exhibit a CAGR of 3.8% | Leading Players: Pfizer Inc, Bayer AG, AstraZeneca, Sanofi, Novartis AG, Merck & Co, Inc & more. | Medgadget
![Launching AI4BetterHearts, the First Global Data Collaborative for Improving Cardiovascular Health | Novartis Foundation Launching AI4BetterHearts, the First Global Data Collaborative for Improving Cardiovascular Health | Novartis Foundation](https://www.novartisfoundation.org/sites/arctic_novartisfoundation/files/2021-01/novartisfoundation-logo-open-graph.jpg)
Launching AI4BetterHearts, the First Global Data Collaborative for Improving Cardiovascular Health | Novartis Foundation
![Amid impressive growth, Novartis' blockbuster Entresto falls short in post-heart attack trial | Fierce Pharma Amid impressive growth, Novartis' blockbuster Entresto falls short in post-heart attack trial | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619531556/FierceImages-EntrestoBottles.jpg/FierceImages-EntrestoBottles.jpg?VersionId=9sTAWwPsLkxrmkYzbyIrvsUHjvZ.b48V)
Amid impressive growth, Novartis' blockbuster Entresto falls short in post-heart attack trial | Fierce Pharma
![Anumana partners with Novartis to develop AI cardiovascular disease detection tools | MobiHealthNews Anumana partners with Novartis to develop AI cardiovascular disease detection tools | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/doctors_laptop_web_xl-GettyImages-1201260156.jpg)